Navigation Links
ACRO Presents at Japan CRO Association Commemorative Symposium
Date:2/26/2009

Joint declaration signed

WASHINGTON and TOKYO, Feb. 26 /PRNewswire-USNewswire/ -- As the voice of the global clinical outsourcing industry, the Association of Clinical Research Organizations (ACRO) had the honor of presenting before the Japan CRO Association's 15th Commemorative Symposium February 26th, 2009 in Tokyo.

ACRO Chair Derek Winstanly, MBChB, discussed "The Modern Day CRO - Expectations" and ACRO Executive Director Douglas Peddicord, Ph.D. addressed "Representing a Global Industry." Dr. Winstanly is Executive Vice President of Strategic Business Development for Quintiles Transnational, a global CRO with offices in 50 countries, including 13 in Japan.

"The drug development process and the clinical outsourcing market are becoming increasingly global in scope, bringing about a need for consistent messaging and positioning of the industry before regulators, lawmakers, research sponsors, patient groups and the public," said Dr. Peddicord.

ACRO joined with JCROA and the European CRO Federation (EUCROF) in signing The Tokyo Declaration, which outlines areas of common interest and cooperation. Tokyo Declaration - Association of Clinical Research Organizations

"The Declaration is another step toward the CRO industry speaking with a unified voice throughout the world," added Peddicord.

About ACRO The Association of Clinical Research Organizations (ACRO) is the professional organization of companies whose focus is clinical research. The association provides an active voice for the CRO industry, which provides specialized services that are integral to the development of drugs, biologics and medical devices. ACRO helps its members improve the quality, efficiency and safety of biomedical research. ACRO member companies employ more than 70,000 professionals worldwide. For more information, please visit www.acrohealth.org.


'/>"/>
SOURCE Association of Clinical Research Organizations
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Zimmer Presents Trabecular Metal Technology Experience at AAOS Annual Meeting
2. Los Angeles Jewish Home Support Group Presents Humanitarian Award and Visionary Award
3. Penn Medicine presents HIV gene therapy trial data at CROI 2009
4. Mexico Presents Flawed Theory in Shooting Death of American Journalist
5. Illinois Department of Veterans Affairs Presents $97,500 Veterans Cash Grant to Alexian Brothers Hospital Network
6. Womans Day Presents the Sixth Annual Red Dress Awards Honoring Women Making Strides in the Fight Against Heart Disease
7. MEDai Presents on Transitioning Predictive Modeling Integration From Care Management to Actuarial Applications
8. Hospital Association Presents Awards for Commitment to Healthcare
9. BoxTone Presents Mobile Industry with Timely Money Back Software Guarantee for Managing Enterprise BlackBerry Platform
10. Inverness Medical Innovations Presents the pima(TM) Point-of-Care CD4 Instrument at ICASA 2008
11. Stem Cells Poised to Grow Organs for Transplant : Zannos Grekos, MD Presents Clinical Data of Research with Adult Stem Cells to Physicians at International Regenerative Biomedicine Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... , ... Five consumer packaged goods (CPG) products were selected by the SupplySide ... Nopavera Plus was named to the short list in the Specialty Supplements category. ... presentations at SupplySide Central on Sept. 27 and 28 at Mandalay Bay Resort in ...
(Date:9/20/2017)... ... 2017 , ... “The Trials I Face to Receive God’s Grace”: a ... aspirations and goals to better one’s life through God. “The Trials I Face to ... all the wrong places, found a love for writing. Green feels that expressing his ...
(Date:9/20/2017)... ... September 20, 2017 , ... “Psalms of Humidity”: is ... of mind and move the readers one step closer to God. “Psalms of Humidity” ... that his mistakes that have been made within his life are the very same ...
(Date:9/19/2017)... ... September 19, 2017 , ... With a series of ... more than $15,000 in just a couple of weeks for those affected by ... world-class instructor seminars, organizers expect to double those initial funds with the “Submit ...
(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... ... Compliance and Safety for the President’s Malaria Initiative (PMI) Africa Indoor Residual ... Innovation to Action Award. , The Innovation to Action Award, a USAID ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly ... it will present new data for galcanezumab and lasmiditan, ... of the International Headache Society (IHC) taking place Sept. ... Lilly will highlight new, long-term data from an ... doses of galcanezumab (120 mg and 240 mg) for ...
(Date:9/5/2017)... Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ORMP) ... the development of oral drug delivery systems, announced today ... U.S. Food and Drug Administration (FDA) regarding ORMD-0801, the ... At the meeting, the FDA gave clear ... would be a Biologics License Application (BLA).  Such a ...
(Date:8/29/2017)... 2017 ivWatch, LLC, the leading provider of continuous monitoring ... has been awarded an Innovative Technology contract from Vizient, Inc., the ... ... in the early detection of peripheral IV infiltration and extravasation events ... The Innovative Technology contract was awarded to ...
Breaking Medicine Technology: